What is Certa Dose?
Certa Dose operates at the intersection of healthcare innovation and patient safety, specializing in the development of intuitive dosing solutions. The company addresses the critical challenge of medical dosing errors, with a primary focus on pediatric care. By integrating hardware solutions like the PALS Syringe Holder Kit with digital support tools such as the Certa Dose App, the firm provides healthcare professionals with visual verification systems that streamline administration processes. This dual-pronged approach is specifically engineered for emergency settings where accuracy is paramount, effectively reducing cognitive load for clinicians and improving outcomes for vulnerable patient populations.
How much funding has Certa Dose raised?
Certa Dose has raised a total of $3.9M across 3 funding rounds:
Debt
$3.5M
Debt
$150K
Debt
$210K
Debt (2017): $3.5M, investors not publicly disclosed
Debt (2020): $150K led by PPP
Debt (2021): $210K supported by PPP
Key Investors in Certa Dose
PPP
Public-Private Partnership
Undisclosed Investor
An undisclosed institutional backer providing strategic capital to support long-term growth and market expansion.
Undisclosed Investor
An undisclosed investor participating in the funding round to support the development of medical safety technologies.
What's next for Certa Dose?
With this major enterprise-level funding, Certa Dose is well-positioned to scale its clinical footprint and expand its product ecosystem. The strategic roadmap likely involves deepening the integration of its digital dosing verification tools within hospital information systems and broadening its reach into new emergency care markets. As the company transitions into its next phase of growth, the focus will remain on leveraging its proprietary technology to set new standards for safety and efficiency in pediatric medicine, ensuring that clinicians have the necessary support to deliver precise care under pressure.
See full Certa Dose company page
